Imatinib is not a potential alternative treatment for uterine leiomyosarcoma.
Serrano C, Mackintosh C, Herrero D, Martins AS, de Alava E, Hernández T, Pérez-Fontán J, Abad M, Pérez A, Serrano E, Bullón A, Orfao A.
Serrano C, et al. Among authors: hernandez t.
Clin Cancer Res. 2005 Jul 1;11(13):4977-9; author reply 4979-80. doi: 10.1158/1078-0432.CCR-04-2461.
Clin Cancer Res. 2005.
PMID: 16000598
Free article.
No abstract available.